Issue 2/2018
Content (19 Articles)
The adolescence of cancer immunotherapy: from a difficult childhood to a pillar of modern anticancer therapy
Thorsten Fuereder
Update and clinical highlights presented at the 2017 American Society of Hematology Meeting
Daniel Heintel
Educational no. 1: Bone marrow diagnostics in hemato-oncological diseases
Michael Vockenhuber, Kurt Wiesinger, Christine Gruber
Update of clinical highlights presented at the 2017 American Society of Hematology Meeting
Sabine Burger, Niklas Zojer, Heinz Ludwig
Acute myeloid leukemia—current data from the 2017 American Society of Hematology meeting
Michael Pfeilstöcker
Indolent lymphoma at ASH (American Society of Hematology) 2017: maintenance revisited
Thomas Nösslinger
My burning issues in aggressive Non Hodgkin’s Lymphoma
David Fuchs, Michael A. Fridrik
Systemic treatment of advanced non-small cell lung cancer: controversies and perspectives
Andreas Tiefenbacher, Robert Pirker
Chimeric antigen receptor T‑cell therapy—a hematological success story
Philipp Wohlfarth, Nina Worel, Georg Hopfinger
Current and future developments of immunotherapy in lung cancer
Laetitia A. Mauti, Tobias Finazzi, Martin Früh, Miklos Pless, Alfred Zippelius, Sacha I. Rothschild
Management of adverse events related to checkpoint inhibition therapy
Jakob Daniel Rudzki
Pitfalls in the radiological response assessment of immunotherapy
Lucian Beer, Maximilian Hochmair, Helmut Prosch
APPLY: A prospective observational study of clinical practice patterns of darbepoetin alfa use in patients with chemotherapy-induced anemia in Romania
Nicoleta Mariana Berbec, Dana Lucia Stanculeanu, Nicoleta Sorina Badelita, Mariana Vasilica, Dorel Ionel Popovici, Andrei Colita, Cristina Neacsu, Alexandru Iordan
JAK2V617F allele burden: innovative concept in monitoring of myeloproliferative neoplasms
Soheila Bagheropur, Ali Ehsanpour, Maryam Tahmasebi Birgani, Najmaldin Saki
Pulmonary mass: never judge a book by its cover
Inke De haes, Yvan Valcke, Koen Deschepper, Elisabeth Beerens, Pieter Goeminne